OptionsHouse

Options Trading News

March 13, 2013  Wed 7:30 AM CT

SPPI: SEE CHART GET CHAIN FIND STRATEGIES

Fusilev Sales to Fall Sharply

Spectrum Pharmaceuticals predicted it will bring in no more than $90 million selling its Fusilev cancer drug this year. That's a huge drop from 2012's $204 million, and the stock is getting hammered. SPPI drops 35 percent before the bell on my tradeMONSTER platform.

Velti Earnings, Revenue Miss

Velti, which provides mobile marketing technology, earned $0.39 a share in the fourth quarter on revenue of $97.5 million. Analysts had expected $0.59 and $106.9 million, respectively. VELT drops 28 percent in the premarket 

ASM Divestiture Leaves Bitter Taste

ASM International said it plans to divest its stake in ASM Pacific Technology, but Bloomberg is reporting that it will result in maximum proceeds of $567 million. Investors had hoped for more, and ASMI is down 13 percent in early trading.

Share this article with your friends


OptionsHouse

Premium Services

Education & Strategy

Using spreads to minimize risk

Last week we discussed the risk vs reward profile of a debit call spread in Wells Fargo (WFC). This week we will run thru the risk vs reward of selling a credit put spread to achieve the same exposure of that debit call spread.

View more education articles »